References
- Silver LL. Challenges in antibiotics discovery. Clin Microbiol Rev. 2011;24(1):71–109. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021209/
- World Bank. Drug resistant infections: a threat to our economic future; 2016 Sept. Available from: http://pubdocs.worldbank.org/en/527731474225046104/AMR-Discussion-Draft-Sept18updated.pdf.
- National Academies of Sciences, Engineering, and Medicine. Making medicines affordable: A national imperative. Washington, DC: The National Academies Press; 2017.
- Alves L, Lexchin J, Mintzes B. Medicines information and the regulation of the promotion of pharmaceuticals. Sci Eng Ethics. 2019;25:1167. Available at..
- Wall LL, Brown D. The high cost of free lunch. Obstet Gynecol. 2007 Jul;110(1):169–173.
- WHO. Drug promotion - what we know, what we have yet to learn. 2005. [cited 2017 Nov 10]. Available from: http://apps.who.int/medicinedocs/pdf/s8109e/s8109e.pdf
- Avorn J. Teaching clinicians about drugs — 50 years later, whose job is it? N Engl J Med. 2011;364:1185–1187.
- Daulaire N, Bang A, Tomson G, et al. Universal access to effective antibiotics is essential for tackling antibiotic resistance. JLME. 2015;43:2.
- So AD, Shah TA. New business models for antibiotic innovation. Ups J Med Sci. 2014;119:176–180.
- 71st UN General Assembly. Political declaration of the high-level meeting on antimicrobial resistance. New York: United Nations; 2016. Available from: http://www.un.org/pga/71/wp-content/uploads/sites/40/2016/09/DGACM_GAEAD_ESCAB-AMR-Draft-Political-Declaration-1616108E.pdf;.
- Edwards SE, Morel CM, Busse R, et al. Combatting antibiotic resistance together: how can we enlist the help of industry? Antibiotics. 2018;7(4):111.
- [cited 2017 Nov 22]. Available from: http://www.genengnews.com/gen-news-highlights/pfizer-buys-astrazeneca-antibiotics-for-up-to-1575b/81253123
- [cited 2019 Oct 7]. Available from: http://www.businesswire.com/news/home/20130311005458/en/Cubist-Obtains-Remaining-Rights-Ceftolozane-Astellas
- [cited 2017 Nov 14]. Available from: https://www.allergan.com/news/news/thomson-reuters/actavis-completes-forest-laboratories-acquisition
- Mossialos E, Morel CM, Edwards SE, et al. Policies and incentives for promoting innovation in antibiotic research. European Observatory on Health Systems and Policies; 2010. Available from: http://www.euro.who.int/data/assets/pdf_file/0011/120143/E94241.pdf.
- AMR Review. Tackling drug-resistant infections globally: final report and recommendations. London: Review on Antimicrobial Resistance; 2016.
- Outterson K, Clift C, Gopinathan U, et al. New business models for sustainable antibiotics. London: Chatham House; 2014.
- Boston Consulting Group. Breaking through the wall a call for concerted action on antibiotics research and development. 2015. Available from: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Gesundheit/Berichte/GUARD_Follow_Up_Report_Full_Report_final.pdf
- The World Bank. Drug resistant infections: a threat to our economic future; 2016 Sept. Available from: http://pubdocs.worldbank.org/en/527731474225046104/AMR-Discussion-Draft-Sept18updated.pdf.
- Forthcoming. publication, OECD.
- Moon S, Erickson E. Universal medicine access through lumpsum remuneration - Australia’s approach to hepatitis C. N Engl J Med. 2019 14. 380(7):607–610.
- WHO. WHO releases the 2019 AWaRe classification antibiotics. 2019. [cited 2019 Sept 21]. Available from: https://www.who.int/medicines/news/2019/WHO_releases2019AWaRe_classification_antibiotics/en/
- Stop TB procurement update: stopTB partnership -global drug facility. 2019. [cited Oct 2019]. Available from: https://extranet.who.int/prequal/sites/default/files/documents/4_Babaley_procurement.pdf
- Kållberg C, Årdal C, Salvesen B, et al. Introduction and geographic availability of new antibiotics approved between 1999 and2014. PLoS One. 2018 Oct 16;13(10):e0205166.
- The World Bank. Drug resistant infections: a threat to our economic future; 2016 Sept. Available from: http://pubdocs.worldbank.org/en/527731474225046104/AMR-Discussion-Draft-Sept18updated.pdf.
- Mendelson M, Dar OA, Hoffman SJ, et al. A global antimicrobial conservation fund for low- and middle-income countries. Inter J Infect Dis. 2016;51:70–72.
- Hoffmann SJ, Outterson K, Rottingen JA, et al. An international legal framework to address antimicrobial resistance. Bull World Health Organ. 2016;93:66.